Should You Listen to Billionaires to Buy Moderna Stock in 2026?
A useful rule of thumb is to think of billionaire interest as a prompt to re-underwrite the story. Question: Can Moderna’s respiratory franchise stabilize and grow with flu, can the oncology pipeline provide a 2nd growth leg in a few years, and is the current valuation adequately discounting clinica
TradingKeyTue, Mar 3